(Q41677105)

6 October 2017

1 reference

title

Immunological mechanisms in atherosclerosis (English)

1 reference

6 October 2017

1 reference

2

G. K. Hansson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9422033

1 December 2024

author name string

T. Yokota

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9422033

1 December 2024

language of work or name

English

0 references

publication date

1 December 1995

1 reference

6 October 2017

December 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9422033

full work available at URL

1 December 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2796.1995.tb01229.x

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9422033

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2796.1995.tb01229.x

1 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2796.1995.tb01229.x

1 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Journal of Internal Medicine

1 December 2024

published in

1 reference

6 October 2017

volume

238

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

479-489

1 reference

Role of basic fibroblast growth factor in vascular lesion formation

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01229.X

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

1 December 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 December 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

1 December 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits

1 December 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Monocytic origin of foam cells in human atherosclerotic plaques

1 December 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

An immunohistochemical analysis of human aortic fatty streaks

1 December 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits

1 December 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis

1 December 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Selectins: interpreters of cell-specific carbohydrate information during inflammation

1 December 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions

1 December 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Activated endothelium binds lymphocytes through a novel binding site in the alternately spliced domain of vascular cell adhesion molecule-1

1 December 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937.

1 December 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

ELAM-1 is an adhesion molecule for skin-homing T cells

1 December 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 December 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium

1 December 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis

1 December 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

1 December 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

1 December 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages

1 December 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Antigen presentation by brain microvessel smooth muscle and endothelium

1 December 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.

1 December 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

1 December 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

1 December 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions

1 December 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemotactic protein

1 December 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 December 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

1 December 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta

1 December 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions

1 December 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

The human hematopoietic colony-stimulating factors

1 December 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma

1 December 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Monocyte-selective transendothelial migration: dissection of the binding and transmigration phases by an in vitro assay

1 December 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes

1 December 2024

45

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity

1 December 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes

1 December 2024

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Role of oxidized low density lipoprotein in atherogenesis

1 December 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes

1 December 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Low density lipoprotein undergoes oxidative modification in vivo

1 December 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 December 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation

1 December 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 December 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events

1 December 2024

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Role of hsp60 during autoimmune and bacterial inflammation

1 December 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65

1 December 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis

1 December 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1

1 December 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis

1 December 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Cell proliferation in human coronary arteries

1 December 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Investigation of the clonality of lymphocytes in Hashimoto's thyroiditis using immunoglobulin and T-cell receptor gene probes

1 December 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

T cells in multiple sclerosis and inflammatory central nervous system diseases

1 December 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis

1 December 2024

66

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Polyclonal origin of T lymphocytes in human atherosclerotic plaques

1 December 2024

67

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits.

1 December 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Effects of human recombinant macrophage colony-stimulating factor on the secretion of lipoprotein lipase from macrophages

1 December 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Detection of activated T lymphocytes in the human atherosclerotic plaque

1 December 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro

1 December 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells

1 December 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

1 December 2024

75

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms

1 December 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages

1 December 2024

79

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide

1 December 2024

82

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells

1 December 2024

83

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells

1 December 2024

84

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein

1 December 2024

85

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Inhibition of endothelial cell proliferation by gamma-interferon

1 December 2024

86

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Mitogenic activity of interferon gamma on growth-arrested human vascular smooth muscle cells

1 December 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells

1 December 2024

89

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Recombinant human macrophage colony-stimulating factor reduces plasma cholesterol and carrageenan granuloma foam cell formation in Watanabe heritable hyperlipidemic rabbits

1 December 2024

90

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty

1 December 2024

91

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo

1 December 2024

92

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

1 December 2024

94

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Interferon-gamma inhibits arterial stenosis after injury

1 December 2024

95

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF

1 December 2024

96

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

T lymphocytes inhibit the vascular response to injury

1 December 2024

97

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Inhibition of leukocyte extravasation with a monoclonal antibody to CD18 during formation of experimental intimal thickening in rabbit carotid arteries

1 December 2024

98

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

1 December 2024

99

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 December 2024

100

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury

1 December 2024

101

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Cyclosporine A Inhibits Induction of DNA Synthesis by PDGF and Other Peptide Mitogens in Cultured Rat Aortic Smooth Muscle Cells and Dermal Fibroblasts

1 December 2024

102

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors

1 December 2024

103

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides

1 December 2024

104

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1 December 2024

105

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

1 December 2024

106

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

1 December 2024

107

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01229.X

1 December 2024

Identifiers

1 reference

6 October 2017

1 reference